Cardiovascular Risk Beyond Low-Density Lipoprotein Cholesterol

被引:8
|
作者
Mayr, Manuel [1 ]
Gerszten, Robert [2 ,3 ]
Kiechl, Stefan [4 ]
机构
[1] Kings Coll London, Kings British Heart Fdn Ctr, 125 Coldharbour Lane, London SE5 9NU, England
[2] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Boston, MA 02215 USA
[4] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
基金
美国国家卫生研究院;
关键词
apolipoproteins; biomarkers; mass spectrometry; nuclear magnetic resonance spectroscopy; precision medicine; INTRACEREBRAL HEMORRHAGE; VULNERABLE PLAQUE; DISEASE RISK; METABOLOMICS; EPIDEMIOLOGY; EFFICACY; GENETICS; BRUNECK; STATINS; EVENTS;
D O I
10.1016/j.jacc.2017.12.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:633 / 635
页数:3
相关论文
共 50 条
  • [41] Low-density lipoprotein cholesterol lowering for the prevention of cardiovascular outcomes in patients with ischemic stroke
    Ntaios, George
    Milionis, Haralampos
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (05) : 476 - 482
  • [42] Novel Low-Density Lipoprotein Cholesterol Reduction Therapies for the Secondary Prevention of Cardiovascular Disease
    Wang, Xing
    Wen, Dingke
    Fang, Mei
    You, Chao
    Ma, Lu
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (10)
  • [43] Assessment of Low-Density Lipoprotein Targets
    Whayne, Thomas F., Jr.
    ANGIOLOGY, 2013, 64 (06) : 411 - 416
  • [44] Interaction of lipoprotein(a) with low-density lipoprotein cholesterol on first incident acute myocardial infarction
    Hu, Yong
    Tao, Jian-Ying
    Cai, Dong-Ping
    He, Yong-Ming
    CLINICA CHIMICA ACTA, 2020, 501 : 1 - 5
  • [45] Association of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population
    Guan, Xu-Min
    Wu, Shou-Ling
    Yang, Xiao-Lei
    Han, Xu
    Yang, Yi-Heng
    Li, Xin-Tao
    Bin Waleed, Khalid
    Du, Yue
    Zhan, Si-Yan
    Liu, Ying
    Li, Hui-Hua
    Xia, Yun-Long
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (06) : 1209 - 1217
  • [46] Low levels of low-density lipoprotein cholesterol and cognitive decline
    Hua, Rong
    Ma, Yanjun
    Li, Chenglong
    Zhong, Baoliang
    Xie, Wuxiang
    SCIENCE BULLETIN, 2021, 66 (16) : 1684 - 1690
  • [47] Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?
    Sniderman, Allan
    McQueen, Matt
    Contois, John
    Williams, Ken
    Furberg, Curt D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (03) : 152 - 155
  • [48] Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein, Apolipoprotein, or Low-Density Lipoprotein Particle What Should Clinicians Measure?
    Davidson, Michael H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (25) : 2616 - 2617
  • [49] Low-Density Lipoprotein Cholesterol and Mortality in Peritoneal Dialysis
    Wu, Xianfeng
    Zhou, Lei
    Zhan, Xiaojiang
    Wen, Yueqiang
    Wang, Xiaoyang
    Feng, Xiaoran
    Wang, Niansong
    Peng, Fenfen
    Wu, Junnan
    FRONTIERS IN NUTRITION, 2022, 9
  • [50] Low-Density Lipoprotein Cholesterol: Is 160 the New 190?
    Virani, Salim S.
    Ballantyne, Christie M.
    CIRCULATION, 2018, 138 (21) : 2326 - 2329